Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$FFZY $0,065
Incredible share structure: OS 56MM Restricted 42MM Float 9.8MM
EXTREMELY UNDERVALUED (will move to 0.25 - 0.60 at least)
Update on Anishinaabe Protector Foundation’s Private Placement Agreement.
Press Release | 07/06/2022
Will Become a Shareholder and Partner of FansFrenzy Corporation (OTC:FFZY) in Future Projects.
Las Vegas, NV, July 6, 2022. FansFrenzy Corporation (the "Company") (OTC: FFZY) is pleased to announce Anishinaabe Protector Foundations investment of six million two hundred and fifty US dollars ($6,250,000) will consist of the following:
Two million dollars ($2,000,000) will result in the issuance of eight million (8,000,000) common shares, and eight million (8,000,000) warrants convertible into common shares at the price of sixty cents ($0.60) per share. The warrants will have a conversion rate of one warrant to one common share.
FansFrenzy will create and issue a special class of non-voting Convertible Preferred Series B shares for the balance of four million two hundred and fifty thousand dollars ($4,250,000). Anishinaabe Protector Foundation therefore becomes a shareholder and partner in our future projects.
About Anishinaabe Protector Foundation
Anishinaabe Protector Foundation is a private Foundation located in NY State. Mission and goals are oriented in the management of assets and investments to improve the well-being of native people and the environment. Consequently, its activities are oriented through the acquisition of lands and investments compatible with the main mission.
Contact information:
Christian-Joseph Turcotte, Vice President
cj@turcotte.us
https://www.otcmarkets.com/stock/FFZY/news/Update-on-Anishinaabe-Protector-Foundations-Private-Placement-Agreement?id=363877
https://www.otcmarkets.com/stock/FFZY/security
$FFZY $0,065
Incredible share structure: OS 56MM Restricted 42MM Float 9.8MM
EXTREMELY UNDERVALUED (will move to 0.25 - 0.60 at least)
Update on Anishinaabe Protector Foundation’s Private Placement Agreement.
Press Release | 07/06/2022
Will Become a Shareholder and Partner of FansFrenzy Corporation (OTC:FFZY) in Future Projects.
Las Vegas, NV, July 6, 2022. FansFrenzy Corporation (the "Company") (OTC: FFZY) is pleased to announce Anishinaabe Protector Foundations investment of six million two hundred and fifty US dollars ($6,250,000) will consist of the following:
Two million dollars ($2,000,000) will result in the issuance of eight million (8,000,000) common shares, and eight million (8,000,000) warrants convertible into common shares at the price of sixty cents ($0.60) per share. The warrants will have a conversion rate of one warrant to one common share.
FansFrenzy will create and issue a special class of non-voting Convertible Preferred Series B shares for the balance of four million two hundred and fifty thousand dollars ($4,250,000). Anishinaabe Protector Foundation therefore becomes a shareholder and partner in our future projects.
About Anishinaabe Protector Foundation
Anishinaabe Protector Foundation is a private Foundation located in NY State. Mission and goals are oriented in the management of assets and investments to improve the well-being of native people and the environment. Consequently, its activities are oriented through the acquisition of lands and investments compatible with the main mission.
Contact information:
Christian-Joseph Turcotte, Vice President
cj@turcotte.us
https://www.otcmarkets.com/stock/FFZY/news/Update-on-Anishinaabe-Protector-Foundations-Private-Placement-Agreement?id=363877
https://www.otcmarkets.com/stock/FFZY/security
Update on Anishinaabe Protector Foundation’s Private Placement Agreement.
Press Release | 07/06/2022
Will Become a Shareholder and Partner of FansFrenzy Corporation (OTC:FFZY) in Future Projects.
Las Vegas, NV, July 6, 2022. FansFrenzy Corporation (the "Company") (OTC: FFZY) is pleased to announce Anishinaabe Protector Foundations investment of six million two hundred and fifty US dollars ($6,250,000) will consist of the following:
Two million dollars ($2,000,000) will result in the issuance of eight million (8,000,000) common shares, and eight million (8,000,000) warrants convertible into common shares at the price of sixty cents ($0.60) per share. The warrants will have a conversion rate of one warrant to one common share.
FansFrenzy will create and issue a special class of non-voting Convertible Preferred Series B shares for the balance of four million two hundred and fifty thousand dollars ($4,250,000). Anishinaabe Protector Foundation therefore becomes a shareholder and partner in our future projects.
About Anishinaabe Protector Foundation
Anishinaabe Protector Foundation is a private Foundation located in NY State. Mission and goals are oriented in the management of assets and investments to improve the well-being of native people and the environment. Consequently, its activities are oriented through the acquisition of lands and investments compatible with the main mission.
Contact information:
Christian-Joseph Turcotte, Vice President
cj@turcotte.us
We should get the financials today, not tomorrow
Leal needs more than 3 months to file the quarterly per 03/30. A few days ago the second quarter ended. They have 3 months to prepare the annual report. Think we get it before X-mas?
Looking back at the May 19 2021 Company Update:
The Company would like to highlight several major accomplishments from 2020 and 2021 thus far:
· The Company is now current(not anymore) and in good standing pursuant to Pink Sheet regulations and guidelines.
· The Company hopes to do another friends and family round at approximately $0.10 in future.
· No director, officer or employee of the Company has sold any of their private placement shares including participants in the Company friends and family offering.
· The Company has acquired Hi-Alloy Valve, LLC and it expects several other acquisitions or mergers by 4Q21.(still waiting) The Company hopes to announce letters of intent for these new acquisition or merger targets in the future.
· The Company intends to be OTC QB qualified by 3Q21(hahahaha). After potential upcoming acquisitions or mergers, the Company intends to become fully audited pursuant to federal guidelines and regulations.
· Manufacturing is still the core competency of the Company’s business, and since its machining capabilities are agnostic to any particular industry, the Company is able to quickly move into new industries and capitalize on specific opportunities as they present themselves.
· The Company originally planned to achieve approximately $100MM in revenue through acquisitions or mergers; however, now the Company has a game plan to meet this goal organically.
Well,..................................
https://www.otcmarkets.com/stock/MVNT/news/Movement-Industries-Corporation-OTC-MVNT-Provides-a-Company-Update?id=303826
Revenue for the 3 months ended December 31st 2021:
$378,221 x 1,84 = $695,927 (target Q1 2022, as expressed by management)
Hi, I admire your optimism, but really these guys suck just like previous VSHC management.
$FFZY $6,25 million private placement announced 06/22/2022
Fansfrenzy Corp $0,085 and free float of less than 10 million shares
https://www.otcmarkets.com/stock/FFZY/security
https://www.otcmarkets.com/stock/FFZY/news/FansFrenzy-Corporation-OTC-FFZY-Announces-a-Funding-Agreement?id=362230
EXTREMELY UNDERVALUED and 84% OF THE OS IS RESTRICTED
$FFZY $6,25 million private placement announced 06/22/2022
Fansfrenzy Corp $0,085 and free float of less than 10 million shares
https://www.otcmarkets.com/stock/FFZY/security
https://www.otcmarkets.com/stock/FFZY/news/FansFrenzy-Corporation-OTC-FFZY-Announces-a-Funding-Agreement?id=362230
EXTREMELY UNDERVALUED and 84% OF THE OS IS RESTRICTED
FansFrenzy Corporation (OTC: FFZY) Announces a Funding Agreement
Press Release | 06/22/2022
Asset management is now the companys core activity.
FANSFRENZY CORPORATION (OTCMKTS:FFZY)
We are excited to have the Anishinaabe Protector Foundation becoming a shareholder and partner in our future projects. Their investment will ensure our continuing commitment to existing shareholders
Bernie Nicholls
LAS VEGAS, NEVADA, UNITED STATES, June 22, 2022 - Las Vegas, NV, June 22, 2022. FansFrenzyCorporation (The "Company") (OTC: FFZY) is pleased to announce a private placement agreement with the Anishinaabe Protector Foundation. The foundation has committed to a major investment of six million two hundred and fifty thousand dollars ($6,250,000).
We are excited to have the Anishinaabe Protector Foundation becoming a shareholder and partner in our future projects. Their investment will ensure our continuing commitment to existing shareholders. saidBernie Nicholls, President of FansFrenzy Corporation. This is a great opportunity for the Company to work with the First Nation Peoples of North America and will help the Company diversify its investments within that community.
The terms of funding will give the Company the sole discretion in every aspect of its decision making.
FansFrenzys long term goal remains the acquisition of undervalued assets and participations in operating businesses. Our current focus is within the province of British Columbia, Canada.
Press release from November 21st 2021:
https://webclarify.com/l8/fansFrenzy%20Corporation%20to%20pursue%20a%20new%20strategy.pdf
Press release from June 16th 2022:
http://webclarify.com/l8/ffprjune162022.pdf
New website (dummy):
http://www.fansfrenzy.com/index.php/en/
Fansfrenzy filed its Q and attorney letter, OTC current information:
https://www.otcmarkets.com/stock/FFZY/security
FANSFRENZY GETS A $6,250,000 PRIVATE PLACEMENT FROM ANISHINAABE PROTECTOR FOUNDATION
did anybody see this PR, it's from June 6th:
http://webclarify.com/l8/ffprjune162022.pdf
Fansfrenzy 6.25 MILLION private placement agreement
OTC:FFZY (Fansfrenzy) $0.075
O/S 56 million Restricted 44 million Free Public Float 12 million
FansFrenzy Corporation (OTC: FFZY) announces a $6,250,000 Funding Agreement
http://webclarify.com/l8/ffprjune162022.pdf
https://www.otcmarkets.com/stock/FFZY/security
Best kept secret in the market. The PR was not shared on OTC or any other main platform. I follow this company already some time. This is BIG. CEO is former NHL superstar Bernie Nicholls. FFZY is OTC CURRENT. Shares will explode
Fansfrenzy 6.25 MILLION private placing agreement
OTC:FFZY (Fansfrenzy) $0.075
O/S 56 million Restricted 44 million Free Public Float 12 million
FansFrenzy Corporation (OTC: FFZY) announces a $6,250,000 Funding Agreement
http://webclarify.com/l8/ffprjune162022.pdf
https://www.otcmarkets.com/stock/FFZY/security
Best kept secret in the market. The PR was not shared on OTC or any other main platform. I follow this company already some time. This is BIG. CEO is former NHL superstar Bernie Nicholls. FFZY is OTC CURRENT. Shares will explode
pathetic performance
Nobody could believe when new management started that they could get to animal testing. Well, here they are. The msu veterinary school is one of the best in the country. Halberd already has the funding. Do your DD
What we're waiting for: * the step-by-step scenario to convert the IP into a commercial product
What we're waiting for: * partner news
What we're waiting for: * scientific article for publication by Dr. Chen (ASU)
What we're waiting for: * government contract
Bernie Nicholls is a BetRegal ambassador, but not doing much over there either. Not sure if BetRegal is successful in Canada
Only good thing is there's no dilution
Take a look at the latest PR that dates back to november last year
What is CEO Bernie Nicholls doing???
We know the company wants to grow organically, but the reason you're all here is you expect MVNT to merge in Velocity and SGR and possibly others. So the big question is, will they announce those mergers in the PR we're expecting this week. If not, you probably have to wait another (2 or 3) year to see a substantial higher stock price.
Before April 1st we get news about:
-) Agreement with 3rd high profile University with Medical School, to start animal testing to develop a cure/treatment for EPILEPSY
-) Large government grant to fund developing cure/treatment for PTSD/CTE
-) Completion of external audit, filing of SEC FORM 10 to upgrade listing to OTCQB (Hartman says they will go for OTCQX)
-) Meeting with NFL/NCAA to seek endorsement for PTSD/CTE research
-) Discussions with identified pharma company for partnership
-) Scientific Articles (by Dr. Chen) for publication in medical magazines
Hartman better hurry to get those PR's out in the next few weeks, time is running out
waiting for their new partners to show up, as mentioned in latest PR
management controlled by Bernie Nicholls
OS updated and no dilution
very, very quiet here
Pink Limited Information!
https://www.otcmarkets.com/stock/HALB/news/Halberd-Medical-Breakthrough-for-the-Treatment-of-Neurodegenerative-Diseases-Affecting-36-Million-Americans-Annually?id=344659
CEO Hartman:
"Our next initiatives are proving efficacy in blood serum and animal testing. Not missing a step, we are in discussions with a major university that specializes in veterinary medicine to undertake animal testing.
We have also contacted several Clinical Research Organizations to investigate FDA certification requirements."
Hartman continued, "As an approved government contractor, we updated our already-approved white paper with the Department of Defense regarding our scientific breakthrough. We similarly informed our NFL representative and NCAA contact to seek their organization's participation in and/or endorsement of our program to develop an efficacious treatment for traumatic brain injuries and the subsequent neurodegenerative diseases that often follow."
From Halberd's twitter account:
Halberd Corporation@HalberdC·13h
(1) Adjunct Professor Hartman is at Youngstown State University observing the attempted in-vitro laser eradication of glutamate. On Monday, Dr. Chen/Arizona State University successfully conjugated the glutamate with antibodies and transmitted the conjugated glutamate to YSU.
Halberd Corporation@HalberdC·13h
(2) Hartman remarked at the impressive attention to detail in the construct of this intricate process – extremely small glutamate conjugation followed by the laser eradication process. Details to follow.
So another PR early next week about successful eradication of Glutamate from CSF. That's no. 10 from their "top 10 target antigens". BIG THINGS HAPPENING HERE. Watch what's next.
Halberd Eliminates 100% of Tau Protein From CSF - The 9th of 10 Target Neurodegenerative Disease Antigens
Press Release | 02/08/2022
Jackson Center, Pennsylvania--(Newsfile Corp. - February 8, 2022) - Halberd Corporation (OTC Pink: HALB) has demonstrated the ability to eliminate 100% of Tau protein from cerebral spinal fluid (CSF) in less than 20 minutes with its patented extracorporeal laser exposure process. Excess Tau in CSF is associated with the onset and progression of Alzheimer's disease and other neurodegenerative diseases. This is the ninth of ten identified neurodegenerative disease target antigens that Halberd has been able to successfully eliminate via its in vitro testing. See Table Below.
Top Ten Neurological Pathogens
Proof of Eradication from CSF Results
Associated Antigens
(Top 10) PTSD/CTE Neurodegenerative Diseases*
Phosphorylated Tau Completed Completed
IL-6 Completed Completed
TNF-a Completed Completed
IL-1 N/A Completed
IL-12 N/A Completed
IL-2 N/A Completed
Beta Amyloid N/A Completed
IL-4 N/A Completed
Tau Completed Completed
Glutamate 1Q22 1Q22
N/A – indicates antigen is not associated with listed condition.
* -- Includes Alzheimer’s, Parkinson’s, Epilepsy & Lou Gehrig’s Diseases
The company also completed duplication tests on the elimination of 100% of the cytokine Interleukin-4 (IL-4) as initially reported in preliminary tests in a previous announcement.
Dr. Mitchell S. Felder, Halberd's Chief Technology Officer and a board-certified attending neurologist stated, "Tau is one of the known precursors to Alzheimer's disease and several other neurodegenerative diseases. What sets Halberd's approach apart is that other competitive efforts primarily focus on treating the symptoms with ingested or injected drugs - adding things to the body - with their associated potential debilitating side effects and drug interactions."
By contrast, Halberd's methodology removes the pathophysiologic basis (cause) of the disease, extracorporeally, avoiding risks associated with injecting foreign substances into the body as explained in this video."
William A. Hartman, Halberd's Chairman, President & CEO added, "Halberd continues its progress towards eliminating excess neurodegenerative antigens from CSF. Halberd previously demonstrated its capability to selectively eliminate specific target antigens from a mixture of pooled antigens in CSF. Glutamate, an excitatory neurotransmitter, is the only remaining target antigen on our list for controlling neurodegenerative disease states through extracorporeal elimination. I am confident our team is up to this challenge and will be successful in eliminating glutamate as well. We anticipate this will be accomplished shortly, at which time, we will be in a position to present our historical research results to organizations interested in treating PTSD, Chronic Traumatic Encephalopathy (CTE), Alzheimer's disease, ALS, epilepsy, and other neurodegenerative diseases. Our goal is to seek partnerships, endorsements and licensing of our technology development leading to effective treatments."
https://www.otcmarkets.com/stock/HALB/news/Halberd-Eliminates-100-of-Tau-Protein-From-CSF---The-9th-of-10-Target-Neurodegenerative-Disease-Antigens?id=342694
I'm afraid we'll get more of the same, let's say 200K (hope I'm wrong)
In 10 days the financials per 12/31/2021 are due. Last quarter revenue was 206K. What do you think: up or down?
So HALB has demonstrated the ability to selectively reduce and control the level of one element in a heterogeneous mixture containing two elements without affecting the levels of the second element. This is fabulous news!
Now they eradicated TAU from CSF as well, only GLUTAMATE remains.
This item stands out for me in the CEO letter and forward goals 2022:
Discussions have commenced and are in progress with a large medical university to develop potential cures for several neurodegenerative diseases with potential independent validation within the year 2022. We plan on sharing the name of this university once an agreement is established.
I did some searching and talked to other shareholders who shared more details on other boards. The cooperation will focus initially to develop a cure for EPILEPSY. In order to treat epilepsy you have to eradicate/control the level of inflammatory cytokines in CSF, especially IL-6 and TNF-alpha. HALB and the new university partner will start animal testing. To know whether HALB's extracorporeal treatment works, you have to "count" the epileptic seizures before and after the treatment. Sounds simple, but is more complicated than that.
We have been waiting for a lot of "old promises" and it seems we get them all in Q1: upgrade listing, start animal testing, large government grant (they're very optimistic), scientific articles for publication, finishing top 10 target antigens in CSF including Glutamate, start removing top 10 target antigens from blood, partner etc.
(ASU and YSU will continue their R&D. I think I know which University/Medical School will start working with HALB, but let's wait for the PR)
Hi, you have been around long enough to know that big pharma can do NOTHING to shut this project down, as all IP is protected by patents (3) and provisional patent applications (20)